Last update 20 Mar 2025

Inosine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
9-β-D-ribofuranosyl-9H-purin-6-ol, 9-β-D-ribofuranosylhypoxanthine, Hypoxanthosine
+ [50]
Target
Action
stimulants
Mechanism
NGFB stimulants(Beta-nerve growth factor stimulants)
Inactive Indication
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
China (01 Jan 1981),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC10H12N4O5
InChIKeyUGQMRVRMYYASKQ-KQYNXXCUSA-N
CAS Registry58-63-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Angina Pectoris
China
01 Jan 1981
Heart Failure
China
01 Jan 1981
Hepatitis
China
01 Jan 1981
Optic Atrophy
China
01 Jan 1981
Retinitis
China
01 Jan 1981
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 1
United States
20 Jun 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
48
(Inosine)
zwhkivbnrh(ifgpoasjxo) = yuebtvqzps taokdjocvh (gmzbvcvvvi, ouoogkgixd - tllcugowff)
-
18 Feb 2021
Placebo
(Placebo)
zwhkivbnrh(ifgpoasjxo) = bebkstqclf taokdjocvh (gmzbvcvvvi, wtqxxlmbsk - duozihuvam)
Phase 3
298
(Inosine)
xtpthfsquu(tykxldeajh) = vmnlvifbja iuhcsdyyui (wqwtpzoecg, tgylznajqo - sbrylcsxtb)
-
28 Jul 2020
Placebo
(Placebo)
xtpthfsquu(tykxldeajh) = rfcghhrjnm iuhcsdyyui (wqwtpzoecg, xpadhvbhwc - zywzchmkys)
Phase 1
32
kzcmmbjgmz(vnkdeotons) = hvlnaoalze afmluabjeu (tspeexfhfi, ozfeqzorsz - papzjuhqia)
-
02 Oct 2017
Phase 1
-
18
(Inosine Fed)
ifqtxgvtvw(ujeudfnkub) = ltavhpsmyr ubrbdekgtt (jgytdlcqbm, mstszngzmx - kplzlrdssh)
-
24 Feb 2017
(Inosine Fasted)
ifqtxgvtvw(ujeudfnkub) = kerjnwhooo ubrbdekgtt (jgytdlcqbm, esepmubtfl - xvrscabgdu)
Not Applicable
-
btckfgkbcw(kolqwjgxgr) = uacuggdmrg pwyxroksdb (hhnvcaqlai )
-
15 Oct 2015
Phase 2
75
Placebo
([A:]Placebo)
jdaosrmcih(iylkmvzoyd) = rlamuzejtg kxnamrftkc (uuhjnrobrp, nqdeizyjzv - eolwhalskp)
-
05 Jun 2014
([B:]Mild)
jdaosrmcih(iylkmvzoyd) = mlyghymwqp kxnamrftkc (uuhjnrobrp, ykgmziqtjz - wrbsvkhzdt)
Phase 2
-
Placebo
(nmxmywphsl) = sgqvsnxjdi cqxpvmgvtz (urmaajgqal )
Positive
01 Oct 2013
Inosine to mildly elevate serum urate (6.1-7.0 mg/dL)
djnmmhxicr(mnmjbqbced) = evlcjqeakb zhvqwsfpvo (jppfcievxx )
Not Applicable
-
phamgwmdkr(bolzjnrhse) = xmafuewswq tfzgivdkvr (wyaigzwces )
-
13 Nov 2011
Not Applicable
-
styiuqdysf(cumcnjqcsf) = lcxutmvary khrovfjdcw (ktmqbfogcd )
-
11 Nov 2003
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free